S. Maanaoui

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

L. Misery, C. Robert, L. Chiche, 2019, Arthritis & rheumatology.

Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey.

B. Dréno, O. Dereure, S. Prey, 2019, Journal of immunotherapy.

Recurrence of chilblains during a second contact with SARS‐CoV‐2: a case report

O. Carpentier, F. Salez, S. Maanaoui, 2021, The British journal of dermatology.

Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey.

B. Dréno, O. Dereure, S. Prey, 2019, Journal of immunotherapy.

Safety of immune checkpoint inhibitors for the treatment of melanoma, bronchopulmonary and urologic neoplasms in patients with preexisting autoimmune disease

G. Quéré, D. Cornec, A. Tison, 2017 .